MDNA Chart
See on advanced chart >
About
Medicenna Therapeutics Corp. was incorporated as A2 Acquisition Corp. under the Alberta Business Corporations Act on February 2, 2015. The company is a clinical stage immuno-oncology company developing novel, highly selective versions of interleukin-2...
Read More
- HighlightA clinical stage immunotherapy company that develops and commercializes Empowered Cytokines and Superkines for the treatment of cancer
- ExchangeNASDAQ
- Listing Date08/24/2020
- Established Date02/02/2015
- Full-time Employees16
- Address2 Bloor St. W. 7th Floor Toronto Ontario M4W 3E2
- Tel1-416-6485555
- Website
- Fiscal Year End Date03/31
- Security TypeCommon Stock
Industry